Abstract:Abstract:: Neurological disorders present a formidable challenge in modern medicine due to the intricate obstacles set for the brain and the multipart nature of genetic interventions. This review article delves into the promising realm of nanoparticle-based gene therapy as an innovative approach to addressing the intricacies of neurological disorders. Nanoparticles (NPs) provide a multipurpose podium for the conveyance of therapeutic genes, offering unique properties such as precise targeting, enhanced stability, and the potential to bypass blood-brain barrier (BBB) restrictions. This comprehensive exploration reviews the current state of nanoparticle-mediated gene therapy in neurological disorders, highlighting recent advancements and breakthroughs. The discussion encompasses the synthesis of nanoparticles from various materials and their conjugation to therapeutic genes, emphasizing the flexibility in design that contributes to specific tissue targeting. The abstract also addresses the low immunogenicity of these nanoparticles and their stability in circulation, critical factors for successful gene delivery. While the potential of NP-based gene therapy for neurological disorders is vast, challenges and gaps in knowledge persist. The lack of extensive clinical trials leaves questions about safety and potential side effects unanswered. Therefore, this abstract emphasizes the need for further research to validate the therapeutic applications of NP-mediated gene therapy and to address nanosafety concerns. In conclusion, nanoparticle-based gene therapy emerges as a promising avenue in the pursuit of effective treatments for neurological disorders. This abstract advocates for continued research efforts to bridge existing knowledge gaps, unlocking the full potential of this innovative approach and paving the way for transformative solutions in the realm of neurological health.

Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases

Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy

Untying a Nanoscale Knotted Polymer Structure to Linear Chains for Efficient Gene Delivery in Vitro and to the Brain

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Highly Branched Poly(β-Amino Ester) Delivery of Minicircle DNA for Transfection of Neurodegenerative Disease Related Cells

Dynamic Nanoassemblies for Imaging and Therapy of Neurological Disorders.

Nanoparticle-based Gene Therapy for Neurodegenerative Disorders

Non-viral gene delivery and therapeutics targeting to brain

Dynamic Nanoassembly-Based Drug Delivery System (DNDDS): Learning from Nature.

Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier

Non‐viral Nucleic Acid Delivery to the Central Nervous System and Brain Tumors

Progress on brain-targeting non-viral gene delivery systems

Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases

Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies

Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration

Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications

Gene therapy for CNS disorders: modalities, delivery and translational challenges

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease

Advances in Brain Delivery Systems Based on Biomimetic Nanoparticles

Gather Wisdom to Overcome Barriers: Well-designed Nano-Drug Delivery Systems for Treating Gliomas

The Landscape of Biomimetic Nanovesicles in Brain Diseases